Cargando…
Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men
OBJECTIVE: To assess basal and insulin-mediated VLDL-triglyceride (TG) kinetics and the relationship between VLDL-TG secretion and hepatic insulin resistance assessed by endogenous glucose production (EGP) in obese and lean men. RESEARCH DESIGN AND METHODS: A total of 12 normoglycemic, obese (waist-...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161323/ https://www.ncbi.nlm.nih.gov/pubmed/21810597 http://dx.doi.org/10.2337/db11-0040 |
_version_ | 1782210677167882240 |
---|---|
author | Sørensen, Lars P. Søndergaard, Esben Nellemann, Birgitte Christiansen, Jens S. Gormsen, Lars C. Nielsen, Søren |
author_facet | Sørensen, Lars P. Søndergaard, Esben Nellemann, Birgitte Christiansen, Jens S. Gormsen, Lars C. Nielsen, Søren |
author_sort | Sørensen, Lars P. |
collection | PubMed |
description | OBJECTIVE: To assess basal and insulin-mediated VLDL-triglyceride (TG) kinetics and the relationship between VLDL-TG secretion and hepatic insulin resistance assessed by endogenous glucose production (EGP) in obese and lean men. RESEARCH DESIGN AND METHODS: A total of 12 normoglycemic, obese (waist-to-hip ratio >0.9, BMI >30 kg/m(2)) and 12 lean (BMI 20–25 kg/m(2)) age-matched men were included. Ex vivo–labeled [1-(14)C]VLDL-TGs and [3-(3)H]glucose were infused postabsorptively and during a hyperinsulinemic-euglycemic clamp to determine VLDL-TG kinetics and EGP. Body composition was determined by dual X-ray absorptiometry and computed tomography scanning. Energy expenditure and substrate oxidation rates were measured by indirect calorimetry. RESULTS: Basal VLDL-TG secretion rates were increased in obese compared with lean men (1.25 ± 0.34 vs. 0.86 ± 0.34 μmol/kg fat-free mass [FFM]/min; P = 0.011), whereas there was no difference in clearance rates (150 ± 56 vs. 162 ± 77 mL/min; P = NS), resulting in greater VLDL-TG concentrations (0.74 ± 0.40 vs. 0.38 ± 0.20 mmol/L; P = 0.011). The absolute insulin-mediated suppression of VLDL-TG secretion was similar in the groups. However, the percentage reduction (−36 ± 18 vs. −54 ± 10%; P = 0.008) and achieved VLDL-TG secretion rates (0.76 ± 0.20 vs. 0.41 ± 0.19 μmol/kg FFM/min; P < 0.001) were impaired in obese men. Furthermore, clearance rates decreased significantly in obese men, but there was no significant change in lean men (−17 ± 18 vs. 7 ± 20%; P = 0.007), resulting in less percentage reduction of VLDL-TG concentrations in obese men (−22 ± 20 vs. −56 ± 11%; P < 0.001). Insulin-suppressed EGP was similar (0.4 [0.0-0.8] vs. 0.1 [0.0-1.2] mg/kg FFM/min (median [range]); P = NS), and the percentage reduction was equivalent (−80% [57–98] vs. −98% [49–100], P = NS). Insulin-mediated glucose disposal was significantly reduced in obese men. CONCLUSIONS: Basal VLDL-TG secretion rates are increased in normoglycemic but insulin-resistant, obese men, resulting in hypertriglyceridemia. Insulin-mediated suppression of EGP is preserved in obese men, whereas suppression of VLDL-TG secretion is less pronounced in obese men. Compared with EGP, the inability to achieve suppression of VLDL-TG secretions to a level similar to control subjects during hyperinsulinemia seems to be an early manifestation in male obesity. |
format | Online Article Text |
id | pubmed-3161323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-31613232012-09-01 Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men Sørensen, Lars P. Søndergaard, Esben Nellemann, Birgitte Christiansen, Jens S. Gormsen, Lars C. Nielsen, Søren Diabetes Metabolism OBJECTIVE: To assess basal and insulin-mediated VLDL-triglyceride (TG) kinetics and the relationship between VLDL-TG secretion and hepatic insulin resistance assessed by endogenous glucose production (EGP) in obese and lean men. RESEARCH DESIGN AND METHODS: A total of 12 normoglycemic, obese (waist-to-hip ratio >0.9, BMI >30 kg/m(2)) and 12 lean (BMI 20–25 kg/m(2)) age-matched men were included. Ex vivo–labeled [1-(14)C]VLDL-TGs and [3-(3)H]glucose were infused postabsorptively and during a hyperinsulinemic-euglycemic clamp to determine VLDL-TG kinetics and EGP. Body composition was determined by dual X-ray absorptiometry and computed tomography scanning. Energy expenditure and substrate oxidation rates were measured by indirect calorimetry. RESULTS: Basal VLDL-TG secretion rates were increased in obese compared with lean men (1.25 ± 0.34 vs. 0.86 ± 0.34 μmol/kg fat-free mass [FFM]/min; P = 0.011), whereas there was no difference in clearance rates (150 ± 56 vs. 162 ± 77 mL/min; P = NS), resulting in greater VLDL-TG concentrations (0.74 ± 0.40 vs. 0.38 ± 0.20 mmol/L; P = 0.011). The absolute insulin-mediated suppression of VLDL-TG secretion was similar in the groups. However, the percentage reduction (−36 ± 18 vs. −54 ± 10%; P = 0.008) and achieved VLDL-TG secretion rates (0.76 ± 0.20 vs. 0.41 ± 0.19 μmol/kg FFM/min; P < 0.001) were impaired in obese men. Furthermore, clearance rates decreased significantly in obese men, but there was no significant change in lean men (−17 ± 18 vs. 7 ± 20%; P = 0.007), resulting in less percentage reduction of VLDL-TG concentrations in obese men (−22 ± 20 vs. −56 ± 11%; P < 0.001). Insulin-suppressed EGP was similar (0.4 [0.0-0.8] vs. 0.1 [0.0-1.2] mg/kg FFM/min (median [range]); P = NS), and the percentage reduction was equivalent (−80% [57–98] vs. −98% [49–100], P = NS). Insulin-mediated glucose disposal was significantly reduced in obese men. CONCLUSIONS: Basal VLDL-TG secretion rates are increased in normoglycemic but insulin-resistant, obese men, resulting in hypertriglyceridemia. Insulin-mediated suppression of EGP is preserved in obese men, whereas suppression of VLDL-TG secretion is less pronounced in obese men. Compared with EGP, the inability to achieve suppression of VLDL-TG secretions to a level similar to control subjects during hyperinsulinemia seems to be an early manifestation in male obesity. American Diabetes Association 2011-09 2011-08-20 /pmc/articles/PMC3161323/ /pubmed/21810597 http://dx.doi.org/10.2337/db11-0040 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Metabolism Sørensen, Lars P. Søndergaard, Esben Nellemann, Birgitte Christiansen, Jens S. Gormsen, Lars C. Nielsen, Søren Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men |
title | Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men |
title_full | Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men |
title_fullStr | Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men |
title_full_unstemmed | Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men |
title_short | Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men |
title_sort | increased vldl-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men |
topic | Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161323/ https://www.ncbi.nlm.nih.gov/pubmed/21810597 http://dx.doi.org/10.2337/db11-0040 |
work_keys_str_mv | AT sørensenlarsp increasedvldltriglyceridesecretionprecedesimpairedcontrolofendogenousglucoseproductioninobesenormoglycemicmen AT søndergaardesben increasedvldltriglyceridesecretionprecedesimpairedcontrolofendogenousglucoseproductioninobesenormoglycemicmen AT nellemannbirgitte increasedvldltriglyceridesecretionprecedesimpairedcontrolofendogenousglucoseproductioninobesenormoglycemicmen AT christiansenjenss increasedvldltriglyceridesecretionprecedesimpairedcontrolofendogenousglucoseproductioninobesenormoglycemicmen AT gormsenlarsc increasedvldltriglyceridesecretionprecedesimpairedcontrolofendogenousglucoseproductioninobesenormoglycemicmen AT nielsensøren increasedvldltriglyceridesecretionprecedesimpairedcontrolofendogenousglucoseproductioninobesenormoglycemicmen |